Device Trial Radar · NCT04431544
AcQMap® US Registry of Procedural and Long-term Clinical Outcomes (Discover-US)
Last checked: Nov 20, 2026Latest source record: Nov 13, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
513
Actual
Start
Sep 29, 2020
Primary completion
Nov 8, 2023
Study completion Nov 8, 2023
Sponsor
- Lead sponsor
- Acutus MedicalNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 16, 2020
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
AcQMap Registry is an observation study
Conditions
- Ablation of Arrhythmia's
Interventions
AcQMap SystemDevice
To evaluate procedural and long-term outcomes when using the diagnostic AcQMap System as an imaging and mapping system for ablation of arrhythmias in accordance with the Instructions for Use (IFU).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Procedural Ablation OutcomesTime frame: 12 hours
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
Grandview Medical Group Research
Birmingham, Alabama
24 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.